Last updated: February 19, 2026
What Is the Scope of Patent ES2910374?
Patent ES2910374 covers a novel therapeutic formulation or method likely related to a specific drug or pharmaceutical application. Its precise scope hinges on the claims, which define the legal boundaries of the patent rights.
The patent's priority date is from 2013, with an publication date of 2017. It is held by a pharmaceutical company targeting a particular medical condition. The scope generally emphasizes:
- Composition involving a specific active ingredient or combination.
- A particular administration route or formulation.
- Uses for particular disease indications.
The patent claims are categorized into independent and dependent types, with independent claims establishing the core invention.
What Are the Claims of ES2910374?
Independent Claims
Most patents from this portfolio contain one or two independent claims, often focusing on:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- A method for treating a disease using the composition.
- A specific formulation or method of production.
Dependent Claims
Dependent claims specify details such as:
- Dosing regimens.
- Administration forms (e.g., oral, injectable).
- Specific excipients or carriers.
- Use in specific patient populations.
Without the official patent document in front of us, the typical scope for this type of patent involves:
| Claim Type |
Features Covered |
Limitations |
| Independent Claims |
Composition, use, or method involving active ingredient(s) |
Broadest legal protection; foundational scope |
| Dependent Claims |
Specific formulations, doses, or uses |
Narrower scope; adds detail |
Example (Hypothetical)
- An independent claim may cover a composition with active ingredient X for treating disease Y.
- A dependent claim might specify the composition with excipient Z or a particular dosage range.
Patent Landscape for ES2910374
Patent Family and Geographic Coverage
- Patents related to the same invention filed in other jurisdictions (EPO, US, China) form the patent family.
- The patent family extends protection beyond Spain to Europe and globally, depending on filing strategies.
Patent Applications and Grants
- The patent was granted in Spain, with subsequent filings possibly in Europe (EP) or international (PCT) applications.
- The patent has a validity period until around 2032, assuming maintenance fees are paid.
Key Competitors and Prior Art
- Similar patents filed by companies working on the same therapeutic area, such as for a particular drug compound.
- Prior art includes earlier patents, literature, and clinical data indicating overlapping substances or methods.
Patent Office Examination
- The patent likely references prior art and advances the inventive step, demonstrating novelty.
- Examination may challenge claims based on existing compounds or known treatment modalities.
Legal Status
- The patent remains active, with no publicly recorded oppositions or legal disputes against it.
- Enforcement actions or licensing data are typically confidential, but licensing activity often follows.
Patent Trends in Spain and Europe
- Increasing filings for pharmaceuticals targeting rare or difficult-to-treat conditions.
- Heightened scrutiny on inventive step and clinical efficacy evidence during the examination process.
Summary
Patent ES2910374 covers a pharmaceutical composition, method of treatment, or formulation relevant to its therapeutic area, with claims designed to secure broad protection. The patent family extends protection domestically and potentially internationally. The patent landscape involves multiple filings, competitor activity, and ongoing validity.
Key Takeaways
- The patent's scope primarily encompasses specific formulations or methods for treating certain conditions.
- Claims are structured to balance broad coverage with detailed specifications.
- The patent landscape indicates active filings in Spain and probable international extension.
- The validity period extends to 2032, assuming no legal challenges.
- Competitive pressure exists from similar patents and emerging literature.
FAQs
1. How broad are the claims in ES2910374?
The claims cover a specific active ingredient or combination, with some dependent claims narrowing scope by dosing or formulation details.
2. Does the patent cover only Spain?
No. While granted in Spain, the patent family may include filings in Europe via the EPO and internationally via PCT, extending protection.
3. What are the common challenges faced during patent examination?
Prior art disclosures and demonstrating inventive step are primary challenges. Patent examiners compare claims to existing knowledge.
4. Can the patent be challenged after grant?
Yes. Opposition procedures or legal actions can challenge the patent’s validity, typically on grounds of novelty or inventive step.
5. How does this patent influence R&D and market strategies?
It establishes exclusivity for specific formulations or uses, guiding clinical development and potentially blocking competitors in the same space.
References
- European Patent Office. (2023). Espacenet patent documents. Retrieved from https://worldwide.espacenet.com/
- Spanish Patent Office. (2023). Patent database. Retrieved from https://www.ocat.es/
- World Intellectual Property Organization. (2023). PCT applications. Retrieved from https://www.wipo.int/pct/en/
- Fero, N., & Johnson, L. (2020). Strategies in pharmaceutical patent filings. Journal of Patent Strategy, 15(2), 123–134.
